Michael Nesrallah will lead global commercial strategy and launch preparation for obefazimod as the company moves toward ...

Recent discussions on X about Abivax (ABVX) have been electrified by the company's announcement of positive Phase 3 trial results for its ulcerative colitis drug, Obefazimod. Many users are ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.

If you are wondering whether ABIVAX Société Anonyme is attractively priced at its current level, the key question is how that share price lines up against its underlying fundamentals. The stock last ...

We came across a bullish thesis on ABIVAX Société Anonyme on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on ABVX. ABIVAX ...

Short interest in Abivax SA (NASDAQ:ABVX) decreased during the last reporting period, falling from 1.82M to 1.24M. This put 1.89% of the company's publicly available shares short. Short interest in ...

According to TipRanks, Slutsky is a top 100 analyst with an average return of 40.2% and a 51.74% success rate. Slutsky covers the Healthcare sector, focusing on stocks such as Palvella Therapeutics, ...

Abivax SA Sponsored ADR (ABVX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...